Transplantation & immunology | Parean Biotechnologies joins a European consortium funded by Horizon Europe

1 April 2022

Parean Biotechnologies is officially partner and consortium member, of Horus Project !

This new approved 7+ Million Euros project, funded by EU H2021, aims to develop new biomarkers and treatments, to improve organ transplantation followup, and assess immune response to CMV in transplanted patients.

Parean Biotechnologies applied for funding with 16 academic and clinical teams, from 9 European countries, under the leadership of Université de Bordeaux / Hannah Kaminski from Julie Dechanet-Merville’s Team.

Parean Biotechnologies will lead data analysis and data integration, generated during this 5-year project, using its cutting-edge datascience knowhow and tools, and deep expertise in immunology. It is looking forward to new research findings impacting transplanted patient’s lives, and honored by the trust of Hannah Kaminski and Julie Dechanet-Merville.